Labcorp Holdings (0JSY) Share Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0JSY Analyst Ratings

Strong Buy

10 Buy

3 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Labcorp

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0JSY Stock 12 Month Forecast

Average Price Target

$380.40

▲(14.25% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Labcorp Holdings in the last 3 months. The average price target is $380.40 with a high forecast of $420.00 and a low forecast of $340.00. The average price target represents a 14.25% change from the last price of $332.94.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"249":"$249","292":"$292","335":"$335","378":"$378","421":"$421"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":420,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$420.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$380.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":340,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$340.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[249,292,335,378,421],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,305.44,314.2523076923077,323.06461538461537,331.87692307692305,340.6892307692308,349.5015384615385,358.31384615384616,367.12615384615384,375.9384615384615,384.75076923076927,393.5630769230769,402.37538461538463,411.1876923076923,{"y":420,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,305.44,311.2061538461538,316.9723076923077,322.73846153846154,328.50461538461536,334.27076923076925,340.0369230769231,345.8030769230769,351.5692307692308,357.3353846153846,363.10153846153844,368.8676923076923,374.63384615384615,{"y":380.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,305.44,308.09846153846155,310.7569230769231,313.4153846153846,316.07384615384615,318.7323076923077,321.39076923076925,324.04923076923075,326.7076923076923,329.36615384615385,332.0246153846154,334.6830769230769,337.34153846153845,{"y":340,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":281.196,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":251.566,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":270.049,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.116,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":284.716,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.943,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.851,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.696,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":283.988,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":311.016,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.66,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305.44,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$420.00

Average Price Target$380.40

Lowest Price Target$340.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Erin Wright

Morgan Stanley

$338→$388

Buy

16.54%

Upside

Reiterated

10/30/26

Erin Wright Reiterates Buy on Labcorp, Raising Price Target to $388 on Strong Execution and Long-Term Earnings Visibility

David Westenberg

Piper Sandler

$309→$365

Hold

9.63%

Upside

Reiterated

10/30/26

Labcorp Holdings (LH) Receives a Hold from Piper Sandler

David S Macdonald

Truist Financial

$365→$395

Buy

18.64%

Upside

Reiterated

10/29/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eric Coldwell

Robert W. Baird

$361→$396

Buy

18.94%

Upside

Reiterated

10/29/26

Labcorp price target raised to $396 from $361 at BairdLabcorp price target raised to $396 from $361 at Baird

Pito Chickering

Deutsche Bank

$306→$355

Hold

6.63%

Upside

Reiterated

10/29/26

Labcorp price target raised to $355 from $306 at Deutsche BankLabcorp price target raised to $355 from $306 at Deutsche Bank

Michael Cherny

Leerink Partners

$365→$410

Buy

23.15%

Upside

Reiterated

10/29/26

Labcorp price target raised to $410 from $365 at LeerinkLabcorp price target raised to $410 from $365 at Leerink

Kevin Caliendo

UBS

$380→$420

Buy

26.15%

Upside

Assigned

10/29/26

Labcorp Holdings (LH) Receives a Buy from UBS

Lu Li

Bank of America Securities

―

Buy

―

Reiterated

10/29/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Bausch + Lomb Corporation (NYSE: BLCO) and SELLAS Life Sciences Group (NASDAQ: SLS)

Luke Sergott

Barclays

$330→$380

Hold

14.13%

Upside

Reiterated

10/28/26

Labcorp price target raised to $380 from $330 at BarclaysLabcorp price target raised to $380 from $330 at Barclays

Jared Haase

William Blair

―

Buy

―

Reiterated

09/11/26

Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets

Elizabeth Anderson CFA

Evercore ISI

$340

Buy

2.12%

Upside

Reiterated

09/11/26

Evercore ISI Remains a Buy on Labcorp Holdings (LH)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

08/26/26

Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp

Ann Hynes

Mizuho Securities

$320→$355

Buy

6.63%

Upside

Reiterated

08/10/26

Labcorp price target raised to $355 from $320 at MizuhoLabcorp price target raised to $355 from $320 at Mizuho

David Toung

Argus Research

$310

Buy

-6.89%

Downside

Reiterated

06/02/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)

Patrick B Donnelly

Citi

$325

Buy

-2.38%

Downside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Erin Wright

Morgan Stanley

$338→$388

Buy

16.54%

Upside

Reiterated

10/30/26

Erin Wright Reiterates Buy on Labcorp, Raising Price Target to $388 on Strong Execution and Long-Term Earnings Visibility

David Westenberg

Piper Sandler

$309→$365

Hold

9.63%

Upside

Reiterated

10/30/26

Labcorp Holdings (LH) Receives a Hold from Piper Sandler

David S Macdonald

Truist Financial

$365→$395

Buy

18.64%

Upside

Reiterated

10/29/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Eric Coldwell

Robert W. Baird

$361→$396

Buy

18.94%

Upside

Reiterated

10/29/26

Labcorp price target raised to $396 from $361 at BairdLabcorp price target raised to $396 from $361 at Baird

Pito Chickering

Deutsche Bank

$306→$355

Hold

6.63%

Upside

Reiterated

10/29/26

Labcorp price target raised to $355 from $306 at Deutsche BankLabcorp price target raised to $355 from $306 at Deutsche Bank

Michael Cherny

Leerink Partners

$365→$410

Buy

23.15%

Upside

Reiterated

10/29/26

Labcorp price target raised to $410 from $365 at LeerinkLabcorp price target raised to $410 from $365 at Leerink

Kevin Caliendo

UBS

$380→$420

Buy

26.15%

Upside

Assigned

10/29/26

Labcorp Holdings (LH) Receives a Buy from UBS

Lu Li

Bank of America Securities

―

Buy

―

Reiterated

10/29/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Bausch + Lomb Corporation (NYSE: BLCO) and SELLAS Life Sciences Group (NASDAQ: SLS)

Luke Sergott

Barclays

$330→$380

Hold

14.13%

Upside

Reiterated

10/28/26

Labcorp price target raised to $380 from $330 at BarclaysLabcorp price target raised to $380 from $330 at Barclays

Jared Haase

William Blair

―

Buy

―

Reiterated

09/11/26

Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets

Elizabeth Anderson CFA

Evercore ISI

$340

Buy

2.12%

Upside

Reiterated

09/11/26

Evercore ISI Remains a Buy on Labcorp Holdings (LH)

Lisa Gill

J.P. Morgan

―

Buy

―

Reiterated

08/26/26

Regulatory Resilience and Strategic Upside Drive Lisa Gill’s Overweight/Buy Rating on Labcorp

Ann Hynes

Mizuho Securities

$320→$355

Buy

6.63%

Upside

Reiterated

08/10/26

Labcorp price target raised to $355 from $320 at MizuhoLabcorp price target raised to $355 from $320 at Mizuho

David Toung

Argus Research

$310

Buy

-6.89%

Downside

Reiterated

06/02/26

Analysts Offer Insights on Healthcare Companies: Labcorp Holdings (NYSE: LH), Moderna (NASDAQ: MRNA) and Celcuity (NASDAQ: CELC)

Patrick B Donnelly

Citi

$325

Buy

-2.38%

Downside

Reiterated

01/02/26

Analysts' Top Healthcare Picks: Doximity (DOCS), Labcorp Holdings (LH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AORTArtivion

MDWDMediwound

IMUXImmunic

RZLTRezolute

DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Labcorp Holdings

3 Months

David S MacdonaldTruist Financial

Success Rate

16/23 ratings generated profit

Average Return

+5.87%

Copying David S Macdonald's trades and holding each position for 3 Months would result in 69.57% of your transactions generating a profit, with an average return of +5.87% per trade.

1 Year

Lisa GillJ.P. Morgan

Success Rate

13/13 ratings generated profit

Average Return

+22.21%

Copying Lisa Gill's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.21% per trade.

2 Years

Lisa GillJ.P. Morgan

Success Rate

13/13 ratings generated profit

Average Return

+37.72%

Copying Lisa Gill's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +37.72% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0JSY Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0JSY has received 18 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. 0JSY average Analyst price target in the past 3 months is 380.40.

Each month's total comprises the sum of three months' worth of ratings.

0JSY Financial Forecast

0JSY Earnings Forecast

Next quarter’s earnings estimate for 0JSY is $4.51 with a range of $4.34 to $4.61. The previous quarter’s EPS was $4.78. 0JSY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0JSY has Performed in-line its overall industry.

0JSY Sales Forecast

Next quarter’s sales forecast for 0JSY is $3.75B with a range of $3.68B to $3.79B. The previous quarter’s sales results were $3.81B. 0JSY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0JSY has Performed in-line its overall industry.

0JSY Stock Forecast FAQ

What is GB:0JSY’s average 12-month price target, according to analysts?

Based on analyst ratings, Labcorp Holdings’s 12-month average price target is 380.40.

What is GB:0JSY’s upside potential, based on the analysts’ average price target?

Labcorp Holdings has 14.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Labcorp Holdings a Buy, Sell or Hold?

Labcorp Holdings has a consensus rating of Strong Buy, which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.

What is Labcorp Holdings’s share price target?

The average share price target for Labcorp Holdings is 380.40. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $420.00 ,and the lowest forecast is $340.00. The average share price target represents 14.25% Increase from the current price of $332.94.

What do analysts say about Labcorp Holdings?

Labcorp Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Labcorp Holdings?

To buy shares of GB:0JSY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Labcorp Holdings (0JSY) Share Forecast & Price Target

0JSY Analyst Ratings

0JSY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Labcorp Holdings

0JSY Analyst Recommendation Trends

0JSY Financial Forecast

0JSY Earnings Forecast

0JSY Sales Forecast

0JSY Stock Forecast FAQ

Detailed List of Analyst Forecasts